Minimally Invasive Surgery Market is Expected to Reach USD 50.60 Billion Globally in 2019: TMR

According to a new market report published by Transparency Market Research “Minimally Invasive Surgery Market (Surgical Devices, Monitoring & Visualization Devices, and Endoscopy Devices) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019,”in 2012, the global minimally invasive surgery market was valued at USD 25.03 billion and is expected to grow at a CAGR of 10.5% during the forecast period 2013 to 2019 to reach a market value of USD 50.60 billion by 2019.

Browse the full Minimally Invasive Surgery Market Report at http://www.transparencymarketresearch.com/minimally-invasive-surgery-market.html

Minimally invasive surgeries (MIS) are performed with minimal incision in the patient’s body and ensure the patients with a reduced duration of hospital stay, minimal patient trauma and reduced recovery time. These advantages associated with MIS along with the rising awareness regarding the same, have increased its popularity among patients as well as physicians.The global market for minimally invasive surgeryhas been estimated togrowat the rate of 10.5% during the forecast period 2013 to 2019. 

This growth is attributed mainly to the increasing incidences of various diseases such as arthritis, cancer and cardiovascular diseases that usually require surgical treatment of the condition. Aging of the global population, especially in the developed countries, will also trigger the growth of this market since elderly people carry a high risk in terms of success of the surgery and MIS would ensure minimal trauma to the already compromised health of the patient. Likewise, introduction of technologically advanced products in the market such as confocal micro endoscopes, narrow band imaging endoscopes and HD cameras for endoscopes, will further propel the growth of this market since these technologies provide better visualization during the surgery.

Minimally invasive surgeries involve three major categories of devices that include surgical devices, monitoring & visualization devices, and endoscopy devices.The market for surgical devices (ablation devices, electrosurgical devices, and medical robotic systems) accounted for the largest share by revenue of the overall MIS market in 2012. This segment is also expected to show the highest growth during the forecast period, at a CAGR of 11.8%. This growth is attributed to their extensive utilization in performing various minimally invasive procedures with maximum accuracy and ease of operation for the physician.

The different types of surgeries that can be performed via minimally invasive technologies include orthopedic, breast, vascular, thoracic, gynecological, bariatric, cardiac, gastrointestinal and urological surgery. Among these, in 2012, the cardiac surgery market accounted for the largest share in terms of revenue due to the large patient population suffering from cardiovascular diseases (CVDs) globally and the ever-increasing incidence rates of CVDs. However, the market for cosmetic surgery will grow at the highest CAGR of 14% during the forecast period 2013 to 2019. This is due to the change in lifestyle of the population along with high adoption rates for these procedures in developed as well as developing markets.


The North American region accounted for the largest share by revenue of the global minimally invasive surgery market in the year 2012, owing to the large number of elderly people, a well-established reimbursement scenario and presence of leading device manufacturers in the region. However, Asia-Pacific is expected to show the highest growth rate of 13.3% from 2013 to 2019. This is attributed to the rise in disposable income due to economic development in key markets such as India and China, and high adoption rates in the developed market of Japan. Similarly, in the constantly increasing patient pool, aging population and rising healthcare expenditures will also augment the growth of the market. The European and RoW markets are expected to show the slowest growth during the forecast period, although the European market is expected to maintain its position with the second largest revenue share in 2019.

The global minimally invasive surgery market is dominated by players such asIntuitive Surgical, Inc., GE Healthcare, Siemens Healthcare, Philips Healthcare, Medtronic, Inc., Stryker Corporation and Biomet, Inc.These companies together accounted for the largest share in terms of revenue in 2012, at over 45%. Some other key players in the market include Abbott Laboratories, DePuy Synthes, Inc., ArthroCare Corporation, Given Imaging Ltd., NuVasive, Inc., Teleflex, Inc. and Varian Medical Systems, Inc.

The global minimally invasive surgery market has been segmented as below:

Minimally Invasive Surgery Market, by Product Type
·         Surgical Devices
o   Ablation Devices
§  Radiofrequency Ablation
§  Microwave Ablation
§  Cryoablation
§  Others
o   Electrosurgical Devices
o   Medical Robotic Systems
·         Monitoring & Visualization Devices
o   X-Ray Devices
o   Computed Tomography (CT) Scanners
o   Magnetic Resonance Imaging (MRI) Equipment
o   UltrasoundEquipment
o   Others
·         Endoscopy Devices

Minimally Invasive Surgery Market, by Type of Surgery
·         Orthopedic Surgery
o   Spinal Surgery
o   Joint Replacement Surgery
·         Cosmetic Surgery
·         Breast Surgery
·         Vascular Surgery
·         Thoracic Surgery
·         Gynecological Surgery
·         Bariatric Surgery
·         Cardiac Surgery
·         Gastrointestinal Surgery
·         Urological Surgery

Minimally Invasive Surgery Market, by Geography
·         North America
·         Europe
·         Asia-Pacific
·         Rest of the World (RoW)


About Us
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact
Ms. Sheela AK
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

Global Amines Market is Expected to Reach USD 13.45 Billion in 2019: TMR

According to a new report published by Transparency Market Research “Amines Market – Global Industry Size, Market Share,Trends, Analysis and Forecast, 2013 – 2019”, the global demand for amines was valued at USD 10.57 billion in 2012 and is expected to reach USD 13.45 billion in 2019, growing at a CAGR of 3.5% between 2013 and 2019. In terms of volume, the demand was 3,635.3 kilo tons in 2012 and is expected to be 4,501.3 kilo tons in 2019, growing at a CAGR of 3.1% between 2013 and 2019.

Browse the full Amines Market Report at http://www.transparencymarketresearch.com/amines-market.html

Increasing demand of agricultural yield, changing lifestyles of consumers and growing construction industry are some of the factors driving the demand for amines. The development of crop protection chemicals industry is expected to be one of the vital factors driving the demand for amines over the next few years. In addition, growth of paints and coatings industry due to numerous factors such as growth in construction and buildings industry is expected to fuel the growth of the market within the forecast period. However, volatile raw material prices and environmental regulations are expected to restraint the growth of the market in the near future. 

Increasing application scope of amines in water treatment coupled with growing demand for amines in personal care industry is expected to open opportunities for the growth of the market over the next few years.

Ethanolamines were the most widely used amines accounting for over 50% of the global demand in 2012. Owing to its versatility, the demand for amines is expected to be substantially high over the forecast period. However, fatty amines are expected to show the fastest growth over the next few years owing to their growing demand in personal care industry.

Crop protection chemicals accounted as the largest application segment for amines in 2012. Amines are being increasingly used in crop protection chemicals to protect crops from insects, pests and fungi. However, the demand for amines is expected to be growing from the surfactant market within the forecast period. Growing demand amines in surfactants due to its ability to increase foam capacity is expected to drive amines market in next few years. Amines demand in surfactant market is expected to be 1,236.9 kilo tons by 2019.


North America dominated the amines market in 2012 followed by Asia Pacific owing to the growth of surfactant industry. Asia Pacific is expected to witness the highest growth within the forecast period on account of increasing usage of crop protection chemicals and surfactant industry. The demand for amines in Asia Pacific is expected to grow at a CAGR of 3.5% between 2013 and 2019.

The report gives a comprehensive view of the amines market in terms of volume and revenue. In addition, the report includes current demand analysis and forecast for each product and application in North America, Europe, China, Asia Pacific and Rest of the World. The report comprises of the following segments:

Amines Market: Product Segment Analysis
§  Ethanolamines
§  Alkylamines
§  Fatty amines
§  Others (Includes cyclic amines, etc.)

Amines Market: Application Analysis
§  Crop protection chemicals
§  Water treatment
§  Personal care
§  Surfactants
§  Others (Includes wood preservations, etc.)

The report also includes similar segmentation for the following regions:

Amines Market: Regional Analysis
§  North America
§  Europe
§  Asia-Pacific
§  Rest of the World
About Us

Transparency Market Research (TMR) is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact
Ms. Sheela AK
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

Teleradiology Market is Expectedto Reach USD 3.78 Billion Globally in 2019: TMR

According to a new market report published by Transparency Market Research “Teleradiology Market (X-ray, Ultrasound, CT, MRI and Nuclear Imaging) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019,” the global teleradiology market was valued at USD 0.92 billion in 2012 and is expected to grow at a CAGR of 22.3% from 2013 to 2019, to reach an estimated value of USD 3.78billion in 2019.

Teleradiology encompasses the electronic transmission of radiography images from a remote location to an urban healthcare set up via internet technology. Teleradiology tends to bridge the gap between the imbalanced demand and supply of radiologists and diagnostic services across the globe. Efficient image transfer demands three major components namely image capture and sending station followed by telecommunication channels (such as internet) and lastly, image receiving station. Initially, the image transfer process was undoubtedly tedious and time consuming coupled with no assurance of image clarity and quality.Presently, teleradiology industry is witnessing the rapid evolution of image processing and transmission tools and technologies.


Presence of avant-garde radiology equipment coupled with hi-tech transmission channels and new age software’s have rendered speed and accuracy to the process. Also, with the increased implementation of PACS, Radiology Information System (RIS), etc. has further favored the production of immediate yet accurate reports to the concerned physician/clinician/surgeon. The burgeoning demand for qualified radiologists, constant technological innovations followed by improved healthcare awareness are some of the major factors that encourage the growth and acceptance of global teleradiology technologies and services. Also, increasing sophistication in medical imaging platforms along with increasing rate of imaging utilization will further drive the development and evolution of teleradiology trends spread across geographies.

Global teleradiology market can be analyzed by four major geographical locations namely, North America, Europe, Asia-Pacific and Rest of the World (RoW). These geographical locations are further evaluated on the basis of the type of imaging modalities being used such as x-ray, ultrasound, computerized tomography (CT) and nuclear imaging.Of these modalities, evolution of x-ray teleradiology has been commendable as compared to other imaging modalities majorly due to low cost, less turnaround time and high level of healthcare awareness.The other lucrative modalities constitute CT, Ultrasound and MRI teleradiology during the forecast period from 2013 to 2019. Consistent technological upgradations of medical imaging equipment followed by improved healthcare informatics enhances the acceptance level of teleradiology technologies and services.

At a regional level, North America was the largest market in 2012 for teleradiology, followed by the European region. This is attributed to rapid technological innovations, large consumer base and high disposable income. Also, presence of well-equipped healthcare institutions along with ready acceptance of novel approaches in medicine will lead to rapid growth and development of teleradiology practices in the above mentioned markets. Asia-Pacific and RoW regions are anticipated to exhibit commendable growth by 2019 due to exhaustive teleradiology service offerings, geographical location advantage and increasing healthcare expenditure in these regions.

Teleradiology market is witnessing constant market consolidation owing to increasing demand for radiologists worldwide coupled with introduction of advanced internet technologies and healthcare informatics. Some of the players of the market include Virtual Radiologic, LLC, Teleradiology Technologies, Stat Rad, Sectra ABand Radisphere National Radiology Group, Inc. are some of the teleradiology service providers.

The global teleradiologymarket is segmented as follows:

Global Teleradiology Market, by Modalities
  • X-ray
  • Ultrasound
  • Computed Tomography (CT)
  • Magnetic Resonance Imaging (MRI)
  • Nuclear Imaging
Global Teleradiology Market, by Geography
·        North America
·        Europe
·        Asia-Pacific
·        Rest of the World (RoW)

About Us
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact
Ms. Sheela AK
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

Drug Device Combination Products Market is Expected to ReachUSD 115.1 Billion Globally in 2019: TMR

According to a new market report published by Transparency Market Research “Drug Device Combination Products Market (Drug Eluting Stents, Infusion Pumps, Photosensitizers, Orthopedic Combination Products, Wound Care Combination Products, Inhalers, Transdermal Patches, Intraocular Implants and Drug Eluting Beads)- Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019,” the global drug device combination productsmarket was valued at USD 66.0 billion in 2012 and is expected to grow at a CAGR of 7.9% from 2013 to 2019, to reach an estimated value of USD 115.1 billion in 2019.

Browse the full Drug Device Combination Products Market Report at http://www.transparencymarketresearch.com/drug-device-combination.html

Drug device combination products are therapeutic products that combine a drug and a medical device chemically and/or physically, to beproduced as a single product. These products can be designed for local as well as systemic drug delivery.With the advances in medical technology, medical devices have changed their definition to more complex devices which assist in improving the efficiency of drugs in therapeutic treatments. These innovations have also made it difficult for regulatory agencies to classify and provide guidelines for safety and validation of these products.Newer developments in drug device combination products have yielded several products for targeted drug delivery within the body. Clinical trials for drug device combination products are more comprehensive and expensive coupled with complications as compared to those required for individual drug and device.

Growing elderly population combined with rise in risk for cardiovascular diseases, asthma and various other chronic disorders contribute to the growth of this market particularly in emerging economies of Middle East, India and China. Moreover, technological advancessuch as biodegradable implants coupled with increase in access and recognition of these technologies in emerging market, will serve as an opportunity for investors to invest in.

The global market for drug device combination products has been studied from the perspective of current widely used various product types.The report provides a detailed analysis of drug eluting stents which are segmented into coronary stents and peripheral vascular stents while the infusion pumps include implantable infusion pumps and ambulatory infusion pumps. Inhalers include metered dose inhalers, dry powder inhalers and nebulizers. The others segment comprises intraocular implants and drug eluting beads. The market estimations for transdermal patches, orthopedic combination products such as bone graft implants and antibiotic loaded bone cements, wound care combination products and photosensitizers have also been provided in the report for the forecast period 2013-2019.

The overall market for drug device combination products is fragmented owing to number of small players involved in respective product segments. In 2012, transdermal patches accounted for the largest share by revenue at USD 25.1 billion of the total drug device combination products market. However, due to the product recalls and consequent stringent regulatory approval procedures, the overall market revenue is expected to decline during the forecast period in the U.S and Europe.The market for inhalers accounted for the second largest share at over USD 20billion in 2012. It is estimated that the global market for inhalers will grow at a CAGR of over 8% from 2013 to 2019, owing to its high incidence rates of asthmatic and chronic obstructive pulmonary disease (COPD) patients.

Geographically, North America dominatedthe global market for drug device combination products in terms of revenue generation and is expected to maintain its position throughout the forecast period. Theadoption of drug eluting stents, implants, growing elderly population and rise in incidences of hypertension and obesity in the U.S., is expected to contribute to the leadership of the North American market. Europe was the second largest regional market for drug device combination productsin 2012, owing to the increased demand for drug eluting stents and infusion pumps.

The global drug device combination products market is dominated by few major players includingBoston Scientific Corporation, Medtronic, Inc., Abbott Laboratories, Inc., CareFusion Corporation and Allergen, Inc.



The global drug device combination products marketis segmented as follows:

Drug Device Combination ProductsMarket, by Product Type
§     Drug Eluting Stents
o     Coronary Stents
o     Peripheral Vascular Stents
§     Infusion Pumps
o     Implantable Infusion Pumps
o     Ambulatory Infusion Pumps
§     Photosensitizers
§     Orthopedic Combination Products
o     Bone Graft Implants
o     Antibiotic Loaded Bone Cement
§     Wound Care Combination Products
§     Inhalers
o     Metered Dose Inhalers
o     Dry Powder Inhalers
o     Nebulizers
§     Transdermal Patches
§     Others
o     Intraocular Implants
o     Drug Eluting Beads
Drug Device Combination Products, by Geography
·        North America
·        Europe
·        Asia-Pacific
·        Rest of the World (RoW)


About Us
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact
Ms. Sheela AK
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

Global Polyacrylamide Market is Expected to Reach USD 6.91 Billion by 2019: TMR

Transparency Market Research has released a new market report titled “Polyacrylamide (Non-ionic, Cationic, Anionic, and Others) Market for Water Treatment, Petroleum, Paper Making and Other Applications - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019,” which observes that the polyacrylamide demand in 2012 was worth USD 3.95 billion and is expected to reach USD 6.91 billion by 2019, growing at a CAGR of 8.4% from 2013 to 2019. In terms of volume, the demand for polyacrylamide was 1,337.5 kilo tons in 2012 and is expected to cross 2,204.5 kilo tons by 2019, growing at a CAGR of 7.4% from 2013 to 2019.
Browse the full Polyacrylamide Market Report at http://www.transparencymarketresearch.com/polyacrylamide-market.html
Polyacrylamide is an important polymer having various end user applications. Key raw materials used in the production of polyacrylamide are acrylamide copolymers and catalysts. The growing environmental concerns regarding both industrial and municipal waste water as well as rapid economic growth in Asia Pacific is expected to remain the major driving force for the polyacrylamide market. Volatile raw material prices are expected to be a key challenge for market participants.
Anionic and cationic were the predominant polyacrylamide product segments, accounting for over 70% of total demand in 2012. Due to its ionic characteristics polyacrylamide is used in various waste water treatment applications. Polyacrylamide used in petroleum applications is anticipated to be the major growth market over the next few years. Growing mining activities across the globe is anticipated to increase the demand for polyacrylamide used in mining. Similar surge in demand is expected to be witnessed from shale gas extraction facilities where polyacrylamide is used as a friction reducer for economical oil recovery.
Asia Pacific accounted for 49% of the total polyacrylamide market in 2012, followed by Europe and North America. Asia Pacific is also expected to be the fastest growing regional market in terms of both polyacrylamide consumption and production. This can be attributed to the growing economies in this region. Skilled labor, cheap availability of raw materials, equipments, and land has resulted in Asia Pacific emerging as a key destination for polyacrylamide producers. Recently various manufacturers have concentrated on capacity expansion in Asia Pacific to increase their production capacities. Europe is the other major region where polyacrylamide consumption was very strong and is expected to grow in demand with a CAGR of about 6.6% in terms of volume from 2013 and 2019.
SNF, BASF SE, Kemira, PetroChina and Beijing Hengju Chemicals are some of the major participants in the polyacrylamide industry.
Polyacrylamide Market, by Product Segment:
·         Non-ionic
·         Cationic
·         Anionic
·         Others (Homopolymers, copolymers, etc.)
Polyacrylamide Market, by Application:
·         Water treatment
·         Petroleum
·         Paper making
·         Others (Chemical, bio-medical, etc.)
Polyacrylamide Market, by Region:
·         North America
·         Europe
·         Asia Pacific
·         Rest of the world (South America, Middle East and Africa)

About Us
Transparency Market Research (TMR) is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact
Ms. Sheela AK
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com/

Global Orthobiologics Market is Expected to Reach USD 5,519.9 Million in 2019: TMR

According to a new market report published by Transparency Market Research  “Orthobiologics Market (Allografts, Viscosupplements, DBM, BMP, Stem Cell and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019, the global orthobiologics market was valued at USD 3,754.6 million in 2012 and is estimated to reach a market worth USD 5,519.9million in 2019at a CAGR of 5.9% from 2013 to 2019.

Orthobiologics are biomaterials used by surgeons for faster healing and quick recovery of injured muscles, bones, ligaments and tendons. It is estimated that bone and joint disorders account for approximately half of the devastating conditions in individuals with above 50 years of age. Moreover, population aged 60 years and above is expected to double by 2020 that alone represents the key driver of this market.

Browse the full Orthobiologics Market Report at http://www.transparencymarketresearch.com/orthobiologics-market.html

A rise in geriatric population, lifestyle changes coupled with growing awareness of sports and outdoor activities among the older as well as younger generation has triggered the growth of this market. Moreover, rise in obese population has concurrently led to rise in prevalence of disorders such as osteoarthritis, rheumatoid arthritis and others. In addition, technological advancements and growing adoption of bone graft substitutes are the other factors that are fuelling the growth of this market.

Viscosupplements represents the largest product segments in the orthobiologics market. Demand for viscosupplements is increasing with the rise in aging population that is more susceptible to osteoarthritic conditions. Moreover, benefits of viscosupplements over (Non-Steroidal Anti Inflammatory Drugs) NSAIDs and other pain relieving treatments has further boosted the growth of this market. Stem cell-based products are expected to show highest growth rate in the near future. Reduced costs, faster healing, quick recovery and ability to mimic autologous bone are some of the major factors anticipated to propel the growth of this market. BMP (Bone Morphogenic Proteins) which is one of the largest revenue contributor of orthobiologics in the past is expected to show a negative growth during the forecast period. 

Recall of INFUSE (Medtronic, Inc.) by the FDA due to heavy off label usage, whichis reported to have serious side effects have created negative impact on its sales. This has hampered the overall BMP market growth. Usage of synthetic bone substitutes is predicted to increase in coming years of forecast, primarily due to a host of factors such as cost effectiveness, improved outcomes and reduction in risk of disease transmission.

Spinal fusion accounted for the largest share of the market due to increase in number of spinal fusion surgeries. According to the American Academy of Orthopedic Surgeons (AAOS), approximately 465,000 spinal surgeries were performed in the U.S in 2011 and this trend is expected to grow in the future owing to rise in geriatric population. The reconstructive surgery market is poised to have thehighest growth from 2013-2019. The growth in this market is attributed to increase in hip and knee replacement surgeries. Moreover, growing awareness about the impact of joint problems and rise in sports related activities is further propelling the growth of this market.

Geographically, North America accounted for the largest share of orthobiologics market in 2012 valued at more than USD 1.5billion in 2012 followed by Europe. However, Asia-Pacific region is expected to represent the highest CAGR of over 6.4% during the forecast period owing to growing awareness about the orthopedic treatment, rising disposable income and rise in incidence of chronic arthritis.

The orthobiologics market is becoming highly lucrative for manufacturers owing to the significant growth opportunities in this field. Moreover, players are seeking to develop alternatives to the standard autograft bone due to risk of infection transmission, limited supply and to avoid lengthy hospital stay. Major players of this market include Medtronic Inc., Stryker Corporation, Sanofi, DePuySynthes, Inc., Globus Medical, Inc., Integra LifeSciences Corporation and others.

The orthobiologics market is segmented as follows:
·         Orthobiologics Market, by Products
§  Allografts
§  Machined Bones
§  Demineralized Bone Matrix (DBM)
§  Bone Morphogenic Protein (BMP)
§  Viscosupplementation
§  Stem cell therapy
·         Orthobiologics Market, by Application
§  Spinal Fusion
§  Trauma
§  Reconstructive Surgeries
·         Orthobiologics Market, by Geography
§  North America
§  Europe
§  Asia-Pacific
§  RoW



About Us
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact
Ms. Sheela AK
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

Global Independent Lubricant Manufacturers Market is Expected to Reach USD 8.5 billion in 2019: TMR

According to a new market report published by Transparency Market Research “Independent Lubricant Manufacturers Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019,”global independent lubricant manufacturers’ market was 4,523.7 kilo tons in 2012 and is expected to reach 5,432.0 kilo tons by 2019 growing at a CAGR of 2.7% from 2013 to 2019.

Rising automotive sales owing to increased applications in the automotive industry, increased regulatory support for bio-based alternatives accompanied by technical support and value added services provided by independent lubricant manufacturers’ are expected to fuel the product demand. Growing applications in the automotive and industrial sectors are likely to drive the market growth rapidly over the coming years. However, volatility in mineral oil prices and high cost of bio-based lubricants are some of the key challenges that are expected to confine the market growth. Increased research and development efforts are expected to pave way for new opportunities for the independent lubricant manufacturers worldwide.

 Browse the full Independent Lubricant Manufacturers Market Report at http://www.transparencymarketresearch.com/independent-lubricant-manufacturers.html

Independent lubricant manufacturers market is classified based on key product segments including automotive and industrial lubricants. Industrial lubricants product segment dominated the overall market in 2012. Rising automotive sales is expected to fuel the automotive lubricants demand over the forecast period. Independent lubricant manufacturers generally supply lubes to OEM car manufacturers and heavy industries namely mining, steel and agricultural industries. Growing application in the heavy industries has significantly bolstered overall market growth.

Asia Pacific dominated the global independent lubricant manufacturers market, accounting for more than 40% of the overall market share in 2012.Asia pacific was followed by North America and Europe. A significant growth in automotive sales was witnessed particularly in the U.S., which are expected to create new opportunities for the U.S. independent lubricant manufacturers. Established automotive industry in Europe comprising of leading OEM car manufacturers are some of the factors expected to fuel automotive lubricants product demand.



Some of the key independent lubricant manufacturers include Fuchs Petrolub AG, Motul, Pentosin, Liqui Moly, Unil-Opal, Carlube, Royal Purple, Amsoil, Red Line and Torco. Fuchs Petrolub AG is one of the leading independent lubricant manufacturers’ that held substantial market share in 2012 and is expected to maintain its position in the near future. The report provides an overview of these companies (global presence and distributors list) followed by their financial revenue, and detailed product portfolio.

This research analyzes and estimates the performance and market of independent lubricant manufacturers in the global scenario, providing detailed trend analysis of the market by geography and comprehensive analysis of companies that are dealing in lubricants. The report presents a thorough assessment of the strategies followed by different stakeholders by segmenting the independent lubricant manufacturers market as below:

§  Independent Lubricants Manufacturers Market: Product Segment Analysis
·         Industrial Lubricants
·         Automotive Lubricants

§  Independent Lubricants Manufacturers Market: Regional Analysis
·         North America
·         Europe
·         Asia-Pacific
·         RoW (Rest of the World)



About Us
Transparency Market Research (TMR) is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact
Ms. Sheela AK
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com


Website: http://www.transparencymarketresearch.com          

Latest Post

Market Research Reports